4/A

FORM 4/A SUBMISSION

Company: Day One Biopharmaceuticals, Inc.
Filed: July 12, 2022
Period of Report: July 1, 2022
Accession Number: 0001209191-22-041994

View Document ↗ View on SEC.gov ↗